Cargando…
p-Hydroxybenzoic Acid Ameliorates Colitis by Improving the Mucosal Barrier in a Gut Microbiota-Dependent Manner
Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disease characterized by intestinal inflammatory cell infiltration and intestinal mucosal damage. The mechanism by which diet contributes to the pathogenesis of IBD remains largely unknown. In this study, we explored the therapeut...
Autores principales: | Han, Xue, Li, Miaomiao, Sun, Lijun, Liu, Xinjuan, Yin, Yue, Hao, Jianyu, Zhang, Weizhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784546/ https://www.ncbi.nlm.nih.gov/pubmed/36558542 http://dx.doi.org/10.3390/nu14245383 |
Ejemplares similares
-
Apigenin remodels the gut microbiota to ameliorate ulcerative colitis
por: Fu, Rongrong, et al.
Publicado: (2022) -
Taraxasterol ameliorates dextran sodium sulfate-induced murine colitis via improving intestinal barrier and modulating gut microbiota dysbiosis: Taraxasterol ameliorates colitis via intestinal barrier and gut microbiota dysbiosis
por: Li, Chen, et al.
Publicado: (2022) -
Potent Intestinal Mucosal Barrier Enhancement of Nostoc commune Vaucher Polysaccharide Supplementation Ameliorates Acute Ulcerative Colitis in Mice Mediated by Gut Microbiota
por: Guo, Min, et al.
Publicado: (2023) -
Antioxidant Mitoquinone Alleviates Chronic Pancreatitis via Anti-Fibrotic and Antioxidant Effects
por: Li, Miaomiao, et al.
Publicado: (2022) -
Paeonol Ameliorates Ulcerative Colitis in Mice by Modulating the Gut Microbiota and Metabolites
por: Zheng, Jiahui, et al.
Publicado: (2022)